The use of vacuolar ATPase inhibitors in the prevention and/or treatment of inflammatory and autoimmune diseases is herein described. Vacuolar ATPase inhibitors are selected among products of natural, semi-synthetic or synthetic origin; more preferred are inhibitors based on a 2- and/or 3-substituted indole, azaindole or benzimidazole structure.
V-Atpase Inhibitors of Use in the Treatment of Septic Shock / C. Farina, G. Constantin, C. Laudanna, P. Misiano.
V-Atpase Inhibitors of Use in the Treatment of Septic Shock
P. MisianoPrimo
2007
Abstract
The use of vacuolar ATPase inhibitors in the prevention and/or treatment of inflammatory and autoimmune diseases is herein described. Vacuolar ATPase inhibitors are selected among products of natural, semi-synthetic or synthetic origin; more preferred are inhibitors based on a 2- and/or 3-substituted indole, azaindole or benzimidazole structure.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.